Moleac Pte Ltd.
- Country
- πΈπ¬Singapore
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.moleac.com
Clinical Trials
8
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)β’ Click on a phase to view related trials
Alzheimer's Disease THErapy With NEuroaid II
- Conditions
- Alzheimer's Disease Dementia
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-09-24
- Last Posted Date
- 2025-09-24
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 350
- Registration Number
- NCT07191028
- Locations
- πΈπ¬
National University Hospital Singapore, Singapore, Singapore
CognivAiD Real-World Evidence Clinical Registry (CONNECT Registry)
- Conditions
- Memory ImpairmentDementia, Vascular
- First Posted Date
- 2024-01-29
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT06228638
- Locations
- πΈπ¬
Raffles Hospital, Singapore, Singapore
MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits
- Conditions
- Strokes ThromboticStroke, IschemicStroke, EmbolicStroke, CryptogenicStrokeStroke, CardiovascularStroke Sequelae
- Interventions
- Other: Placebo
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2025-09-05
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT05289947
- Locations
- π΅π
Metro Davao Medical And Research Center, Davao City, Davao Region, Philippines
π΅πQuirino Memorial Medical Center, Manila, Manila, Philippines
π΅πUniversity of Santo Tomas Hospital, Manila, Manila, Philippines
MLC1501 Study Assessing Efficacy in STROke Recovery
- Conditions
- StrokeStroke, CardiovascularStroke, CryptogenicStroke, EmbolicStroke, IschemicStrokes ThromboticStroke Sequelae
- Interventions
- Other: Placebo
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 540
- Registration Number
- NCT05046106
NeuroAiD IIβ’ (MLC901) in Mild Traumatic Brain Injury
- Conditions
- Traumatic Brain Injury
- First Posted Date
- 2021-04-27
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 182
- Registration Number
- NCT04861688
- Locations
- π·πΊ
Nizhny Novgorod regional clinical hospital named after N. A. Semashko, Nizhny Novgorod, Russian Federation
π·πΊState Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation
π·πΊMunicipal Polyclinic β 106 of St.Petersburg, Saint Petersburg, Russian Federation
- Prev
- 1
- 2
- Next